 | | |
| |
|
| |
|
Appointments
|
|
Associate Professor of Public Health
|
|
|
|
|
| |
Schackman, Bruce R.
 (212) 746-6625  (212) 746-8544
- Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KA. Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Am J Publ Health 2001; 91:1456-63.
- Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J, Weinstein MC. A comparison of health state utilities using community and patient preference weights derived from a survey of HIV/AIDS patients. Med Decis Making. 2002; 22:27-38.
- Schackman BR, Freedberg KA, Weinstein MC, Sax P, Zang H, Goldie SJ. Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med. 2002; 162:2478-2486.
- Schackman BR, Teixera PA. Quality of life of HCV-infected patients in urban methadone and HIV clinics [Abstract]. Quality of Life Research 2003; 12:808.
- Schackman BR, Gold HT, Stone PW, Neumann PJ. How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions? PharmacoEconomics. 2004; 22:293-300.
- Gulick RM, Ribaudo RJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA 3rd, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR. Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV-1 infection: AIDS Clinical Trials Group (ACTG) Study A5095. N Engl J Med. 2004; 350: 1850-61
- Schackman BR, Oneda K, Goldie SG. The cost-effectiveness of elective cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS. 2004;18:1827-34.
- Brannigan R, Schackman BR, Falco M, Millman RB. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey. Arch Pediatr Adolesc Med. 2004; 158:904-9.
- Honkanen LA, Schackman BR, Mushlin AI, Lachs M. A cost-benefit analysis of external hip-protectors in the nursing home setting. J Am Geriatr Soc. 2005; 53:190-7.
- Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen, AP, Neumann PJ. A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis. 2005; 5:383-91.
- Schackman BR, Freedberg KA, Goldie SJ, Weinstein MC, Swartz K. Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment in Georgia and Massachusetts. Health Care Financ Rev. 2005; 26:67-80.
- Dunn WR, Schackman BR, Walsh C, Lyman S, Jones EC, Warren RF, Marx RG. Variation in orthopaedic surgeons? perceptions about the indications for rotator cuff surgery. J Bone Joint Surg Am. 2005; 87-A:1978-1984.
- Schackman BR, Finkelstein R, Neukermans CP, Lewis L, Eldred L, for the Center for Adherence Support and Evaluation (CASE) team. The cost of HIV medication adherence support interventions: results of a cross-site evaluation. AIDS Care. 2005; 17:927-937.
- Mrus JM, Schackman BR, Wu AW, Freedberg KA, Tsevat J, Yi MS, Zackin R. Variations in self-rated
health among patients with HIV infection. Qual Life Res 2006; 15:503-14. - Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The survival benefits of AIDS treatment in the United States. J. Infect Dis In Press.
- Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore R, Freedberg KA. The lifetime cost of current HIV care in the United States. Medical Care In Press.
|
| |
|
| |
|
|
|
|
Back to Top